NEURODEGENERATIVE DISEASE
Clinical trials for NEURODEGENERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new NEURODEGENERATIVE DISEASE trials appear
Sign up with your email to follow new studies for NEURODEGENERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy aims to halt rare, devastating nerve disease
Disease control OngoingThis Phase 3 trial is testing whether a single dose of an experimental gene therapy called NTLA-2001 can safely slow or stop the progression of hereditary amyloidosis with polyneuropathy (ATTRv-PN), a rare genetic disease that damages nerves. About 50 participants worldwide will …
Matched conditions: NEURODEGENERATIVE DISEASE
Phase: PHASE3 • Sponsor: Intellia Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists build massive online brain database to fight Alzheimer's
Knowledge-focused ENROLLING_BY_INVITATIONThis study is building a large online registry of people interested in brain research. Participants answer health and lifestyle questionnaires and take online memory tests over time. The goal is to help scientists understand brain health and find people for future research studie…
Matched conditions: NEURODEGENERATIVE DISEASE
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC